Oxford Biomedica plc (LON:OXB)
624.00
-14.00 (-2.19%)
At close: Mar 6, 2026
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 754.25 million as of March 6, 2026. Its market cap has increased by 112.46% in one year.
Market Cap
754.25M
Enterprise Value
805.80M
Revenue
151.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
624.00
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 754.25M, an increase of 4,236.34%. That is a compound annual growth rate of 14.16%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.20B |
| Genus | 1.83B |
| PureTech Health | 303.71M |
| Avacta Group | 299.62M |
| Scancell Holdings | 129.98M |
| 4basebio | 83.58M |
| Bioventix | 78.37M |
| Faron Pharmaceuticals Oy | 67.15M |